Cardio Diagnostics Valuation
| CDIOW Stock | USD 0.04 0.0001 0.24% |
Cardio Diagnostics seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cardio Diagnostics from analyzing the firm fundamentals such as Revenue of 17.07 K, operating margin of (162.96) %, and Return On Equity of -2.93 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cardio Diagnostics' price fluctuation is out of control at this time. Calculation of the real value of Cardio Diagnostics is based on 3 months time horizon. Increasing Cardio Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cardio stock is determined by what a typical buyer is willing to pay for full or partial control of Cardio Diagnostics Holdings. Since Cardio Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cardio Stock. However, Cardio Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.041 | Real 0.0267 | Hype 0.04 | Naive 0.0401 |
The intrinsic value of Cardio Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cardio Diagnostics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cardio Diagnostics Holdings helps investors to forecast how Cardio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cardio Diagnostics more accurately as focusing exclusively on Cardio Diagnostics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cardio Diagnostics' intrinsic value based on its ongoing forecasts of Cardio Diagnostics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cardio Diagnostics' closest peers.
Cardio Diagnostics Cash |
|
Cardio Valuation Trend
Analysing the historical paterns of Cardio Diagnostics' enterprise value and its market capitalization is a good way to estimate and gauge the value of Cardio Diagnostics Holdings over time and is usually enough for investors to make rational market timing decisions.
Cardio Diagnostics Total Value Analysis
Cardio Diagnostics Holdings is currently estimated to have takeover price of 0 with market capitalization of 0, debt of 1.26 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cardio Diagnostics fundamentals before making investing decisions based on enterprise value of the companyCardio Diagnostics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cardio Diagnostics has an asset utilization ratio of 0.38 percent. This indicates that the Company is making $0.003824 for each dollar of assets. An increasing asset utilization means that Cardio Diagnostics Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Cardio Diagnostics Profitability Analysis
The company reported the revenue of 17.07 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 0.About Cardio Diagnostics Valuation
Our relative valuation model uses a comparative analysis of Cardio Diagnostics. We calculate exposure to Cardio Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cardio Diagnostics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -94.6 K | -89.8 K | |
| Pretax Profit Margin | (490.88) | (515.42) | |
| Operating Profit Margin | (424.40) | (445.62) | |
| Net Loss | (490.88) | (515.42) | |
| Gross Profit Margin | (5.54) | (5.82) |
Cardio Diagnostics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cardio Diagnostics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 12.7 M |
Cardio Diagnostics Current Valuation Indicators
Valuation refers to the process of determining the present value of Cardio Diagnostics Holdings and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Cardio we look at many different elements of the entity such as Cardio's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cardio Diagnostics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cardio Diagnostics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cardio Diagnostics' worth.Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.